Other

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

Merck & Co. Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number increased by 2.9% to $9.35M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.9%, from $9.08M to $9.35M. Over 5 years (FY 2020 to FY 2025), Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number shows a downward trend with a -6.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalLower is better
VolatilityStable
First reportedQ4 2015
Last reportedQ4 2025Feb 24, 2026

How to read this metric

An increase indicates a larger pool of exercisable options, which may lead to higher share issuance and dilution in the near term.

Detailed definition

This represents the total number of stock options that have vested and are currently eligible for exercise by employees....

Peer comparison

Standard metric for evaluating equity-based compensation overhang at public companies.

Metric ID: other_share_based_compensation_arrangement_by_share_base_086dc0

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$12.14M$8.73M$9.45M$9.08M$9.35M
QoQ Change—-28.1%+8.3%-3.9%+2.9%
YoY Change—-28.1%+8.3%-3.9%+2.9%
Range$8.73M – $12.14M
CAGR-23.0%
Avg YoY Growth-5.2%
Median YoY Growth-0.5%

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number at Other Companies

Viatris logo
ViatrisVTRSView metric

Frequently Asked Questions

What is Merck & Co.'s share based compensation arrangement by share based payment award options exercisable number?
Merck & Co. (MRK) reported share based compensation arrangement by share based payment award options exercisable number of $9.35M in Q4 2025.
How has Merck & Co.'s share based compensation arrangement by share based payment award options exercisable number changed year-over-year?
Merck & Co.'s share based compensation arrangement by share based payment award options exercisable number increased by 2.9% year-over-year, from $9.08M to $9.35M.
What is the long-term trend for Merck & Co.'s share based compensation arrangement by share based payment award options exercisable number?
Over 5 years (2020 to 2025), Merck & Co.'s share based compensation arrangement by share based payment award options exercisable number has grown at a -6.6% compound annual growth rate (CAGR), from $13.14M to $9.35M.
What does share based compensation arrangement by share based payment award options exercisable number mean?
The total number of stock options that employees are currently allowed to use to purchase company shares.